ADVERTISEMENT
Cook Medical and Bentley Enter Distribution Agreement for the BeBack Catheter in the United States
Bloomington, Ind. — Cook Medical and Bentley announced a United States distribution agreement for the BeBack Catheter. Over the coming months, Cook Medical will be assuming commercial responsibilities for this Bentley product.
“We are excited to welcome Bentley’s BeBack catheter to our peripheral intervention portfolio,” said Alec Cerchiari, director of product management for Cook’s PAD and Venous specialty. “The BeBack Catheter is a unique tool for crossing heavily calcified lesions in antegrade or retrograde fashion. It complements Cook’s robust portfolio of above- and below-the-knee products, including our Micropuncture® Pedal Introducer Access Sets, Flexor® Guiding Sheaths and CXI® Support Catheter. ”
The BeBack is a crossing catheter designed for steering through chronic total occlusions (CTO) that provides targeted reentry options. The catheter includes features such as:
- A steerable and adjustable nitinol needle
- A radiopaque marker located near the tip of the catheter, which indicates the direction in which the needle curves
- 80 and 120 cm lengths and 2.9F and 4F sizes
“The BeBack catheter is an effective approach for successful recanalisation and should be available in every lab across the U.S. Thanks to this collaboration with Cook, we will now have a better commercial footprint in the U.S. with even more opportunities to treat patients with debilitating arterial and venous disease,” said Martijn Nugteren, director of sales & marketing at Bentley.
Distribution partnerships, such as this one with Bentley, allow Cook to accelerate our product pipeline and bring innovative products to our customers and their patients. Cook and Bentley have a long history of collaboration, and this partnership represents another example of us working together to advance patient care.
You can learn more about the BeBack® product here.
About Cook Medical
Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we invent, manufacture and deliver a unique portfolio of medical devices to the healthcare systems of the world. Serving patients is a privilege, and we demand the highest standards of quality, ethics and service. We have remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.
Find out more at CookMedical.com and for the latest news, follow us on Twitter, Facebook and LinkedIn.
About Bentley
Founded in 2009 by Lars Sunnanväder and Miko Obradovic, Bentley InnoMed GmbH is based in the medical technology stronghold of Hechingen in Baden-Wurttemberg, Germany. The company develops, manufactures, and markets implants and catheters for the endovascular treatment of peripheral vascular and aortic diseases. The company has since then become a leading global manufacturer and the European market leader for covered stents. The company is part of the Bentley Endovascular Group. More than 400 employees are committed to the Group’s strong culture of innovation, making Bentley one of the most important employers in the county of Zollernalb and beyond. In 2022, the company generated sales revenue of EUR 69 million. Based on its product innovations and the development of new markets, the company is on a path of strong growth momentum.
Find More:
The Latest Clinical & Industry News
Grand Rounds With Morton Kern, MD
